BUZZ-Fast LNG facility shuts down, New Fortress Energy stock falls
路透社2026/10/05 16:41On October 5, shares of U.S. liquefied natural gas company New Fortress Energy (NFE.O) fell 14.3% to a historic low of $5.63. NFE stated that its Fast LNG facility was shut down due to a mechanical failure in the plant's gas turbine. The company added that it is actively working with the turbine manufacturer to restore the Fast LNG facility to operation as soon as possible. NFE expects the Fast LNG facility to resume operations in the fourth quarter. Including the decline from this trading day, the stock has fallen a cumulative 90.1% this year. (For the convenience of non-English speakers, Reuters has automated the translation of its reports into several other languages. Due to possible errors in automated translation or a lack of necessary context, Reuters does not guarantee the accuracy of translated texts and provides them solely for readers’ convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation.)
October 5 - ** U.S. liquefied natural gas company New Fortress Energy NFE.O shares fell 14.3%, hitting a new record low of $5.63
** NFE stated that its Fast LNG facility was shut down due to a mechanical failure in a gas turbine at the site (link)
** The company added that it is actively working with the turbine manufacturer to restore the Fast LNG facility operations as soon as possible
** NFE expects the Fast LNG facility to resume operations in the fourth quarter
** Including today's decline, the stock is down 90.1% year-to-date
(To facilitate users whose native language is not English, Reuters has automated its reports into several other languages. Because automated translation may contain errors or may not include the required context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for the convenience of readers. Reuters accepts no responsibility for any damage or loss caused by the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Will the 30-year yield break 6% this month? Economic resilience and inflation pressures drive rates higher, further intensifying the sell-off in US Treasury bonds
U.S. Treasury bonds faced another round of sell-offs on Monday, pushing long-term yields to their highest levels in decades.
Strive CEO Says ASST Can Outrun Strategy in the Next Bitcoin Bull Market
Allegion Buys Overly Door Company
05:37 PM EDT, 10/05/2026 (MT Newswires) -- Allegion (ALLE) said late Monday it has acquired privately held Overly Door Company, a manufacturer of custom specialty doors for acoustic, blast, bullet-resistant and vault security. Overly, based in Greensburg, Pennsylvania, will operate as part of the Allegion Americas segment, it said. Terms of the transaction weren't disclosed.
Updated Version 3 - According to the Financial Times, McKesson and CD&R are close to reaching a deal worth more than $5 billion to acquire Option Care.
In the fifth paragraph, a quote from analyst Sahil Pandey was added. Reuters, October 5 - According to the Financial Times, citing informed sources, pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are about to reach an acquisition agreement to purchase infusion service provider Option Care Health, with the deal valued (including debt) at over 5 billions USD. After the report was published, Option Care's share price rose by 21% in after-hours trading. The report stated that the deal could be announced as early as Tuesday, but negotiations could still fall through. This potential acquisition would be McKesson’s latest move in expanding its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about 2.25 billions USD (link), as part of its effort over the years to strengthen high-growth business sectors. Leerink Partners analyst Michael Cherny said the “strategic logic” of the deal makes sense, as it would expand McKesson’s business from physician offices to care settings in the home and alternative sites. Option Care provides infusion services that allow patients to receive intravenous treatments at home or other outpatient settings, eliminating the need to go to the hospital. McKesson has previously been restructuring its business portfolio by divesting non-core assets and investing in fields such as oncology and specialty care (link). Driven by the growth of its specialty distribution business and contributions from acquisitions, revenue for its oncology and multi-specialty business segment grew by 33% in the latest fiscal quarter. McKesson declined to comment, while CD&R and Option Care did not immediately respond to Reuters’ requests for comment regarding the report. (For non-English speakers' convenience, Reuters offers automated machine translations of its reports in several languages. As there may be mistakes in the automated translations or some context may not be included, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translation functions.)
Crypto prices
More
